-
1
-
-
0026803020
-
Appropriate acid suppression for the management of gastro-oesophageal reflux disease
-
Bell NJ, Burget D, Howden CW et al. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion 1992 51 (Suppl. 1 59 67.
-
(1992)
Digestion
, vol.511
, pp. 59-67
-
-
Bell, N.J.1
Burget, D.2
Howden, C.W.3
-
2
-
-
0028309047
-
Appropriate acid suppression for optimal healing of duodenal ulcer and gastro-oesophageal reflux disease
-
Howden CW, Burget DW, Hunt RH. Appropriate acid suppression for optimal healing of duodenal ulcer and gastro-oesophageal reflux disease. Scand. J. Gastroenterol. Suppl. 1994 201 : 79 82.
-
(1994)
Scand. J. Gastroenterol. Suppl.
, vol.201
, pp. 79-82
-
-
Howden, C.W.1
Burget, D.W.2
Hunt, R.H.3
-
3
-
-
0029811274
-
Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease
-
Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996 111 : 1192 9.
-
(1996)
Gastroenterology
, vol.111
, pp. 1192-1199
-
-
Vaezi, M.F.1
Richter, J.E.2
-
4
-
-
85034892766
-
Sensitivity of esophageal mucosa to pH in gastroesophageal reflux disease
-
Smith JL, Opekun AR, Larkai E et al. Sensitivity of esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology 1989 96 : 683 9.
-
(1989)
Gastroenterology
, vol.96
, pp. 683-689
-
-
Smith, J.L.1
Opekun, A.R.2
Larkai, E.3
-
5
-
-
0033548841
-
Importance of pH control in the management of GERD
-
Hunt RH. Importance of pH control in the management of GERD. Arch. Intern. Med. 1999 159 : 649 57.
-
(1999)
Arch. Intern. Med.
, vol.159
, pp. 649-657
-
-
Hunt, R.H.1
-
6
-
-
0034798223
-
Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole
-
Andersson T, Rohss K, Bredberg E et al. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole. Aliment. Pharmacol. Ther. 2001 15 : 1563 9.
-
(2001)
Aliment. Pharmacol. Ther.
, vol.15
, pp. 1563-1569
-
-
Andersson, T.1
Rohss, K.2
Bredberg, E.3
-
7
-
-
0034466498
-
Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects
-
Hassan-Alin M, Andersson E, Bredberg E et al. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects. Eur. J. Clin. Pharmacol. 2000 56 : 665 70.
-
(2000)
Eur. J. Clin. Pharmacol.
, vol.56
, pp. 665-670
-
-
Hassan-Alin, M.1
Andersson, E.2
Bredberg, E.3
-
8
-
-
0033947414
-
Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of gastro-oesophageal reflux disease
-
Lind T, Rydberg L, Kyleback A et al. Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 2000 14 : 861 7.
-
(2000)
Aliment. Pharmacol. Ther.
, vol.14
, pp. 861-867
-
-
Lind, T.1
Rydberg, L.2
Kyleback, A.3
-
9
-
-
0036238720
-
Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease
-
Rohss K, Hasselgren G, Hedenstrom H. Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease. Dig. Dis. Sci. 2002 47 : 954 8.
-
(2002)
Dig. Dis. Sci.
, vol.47
, pp. 954-958
-
-
Rohss, K.1
Hasselgren, G.2
Hedenstrom, H.3
-
10
-
-
1342280463
-
Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers
-
Wilder-Smith CH, Rohss K, Nilsson-Pieschl C et al. Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers. Digestion 2003 68 : 184 8.
-
(2003)
Digestion
, vol.68
, pp. 184-188
-
-
Wilder-Smith, C.H.1
Rohss, K.2
Nilsson-Pieschl, C.3
-
11
-
-
10644282356
-
Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: Results of a randomized study
-
Wilder-Smith CH, Rohss K, Bondarov P et al. Esomeprazole 40 mg i.v. provides faster and more effective intragastric acid control than pantoprazole 40 mg i.v.: results of a randomized study. Aliment. Pharmacol. Ther. 2004 20 : 1099 104.
-
(2004)
Aliment. Pharmacol. Ther.
, vol.20
, pp. 1099-1104
-
-
Wilder-Smith, C.H.1
Rohss, K.2
Bondarov, P.3
-
12
-
-
8744284238
-
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms
-
Rohss K, Lind T, Wilder-Smith C. Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. Eur. J. Clin. Pharmacol. 2004 60 : 531 9.
-
(2004)
Eur. J. Clin. Pharmacol.
, vol.60
, pp. 531-539
-
-
Rohss, K.1
Lind, T.2
Wilder-Smith, C.3
-
13
-
-
18144440017
-
Genetic variations of S-mephenytoin 4′-hydroxylase (CYP2C19) in the Chinese population
-
Xie HG. Genetic variations of S-mephenytoin 4′-hydroxylase (CYP2C19) in the Chinese population. Life Sci. 2000 66 : PL175 81.
-
(2000)
Life Sci.
, vol.66
-
-
Xie, H.G.1
-
14
-
-
0030580125
-
Genotype analysis of the CYP 2C19 gene in the Japanese population
-
Tsuneoka T, Fukushima K, Yoshinori M et al. Genotype analysis of the CYP 2C19 gene in the Japanese population. Life Sci. 1996 20 : 1711 15.
-
(1996)
Life Sci.
, vol.20
, pp. 1711-1715
-
-
Tsuneoka, T.1
Fukushima, K.2
Yoshinori, M.3
-
15
-
-
0036127851
-
Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis
-
Castell DO, Kahrilas PJ, Richter JE et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am. J. Gastroenterol. 2002 97 : 575 83.
-
(2002)
Am. J. Gastroenterol.
, vol.97
, pp. 575-583
-
-
Castell, D.O.1
Kahrilas, P.J.2
Richter, J.E.3
-
16
-
-
0033785204
-
Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux esophagitis patients: A randomized controlled trial
-
Kahrilas PJ, Falk GW, Johnson DA et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux esophagitis patients: a randomized controlled trial. Aliment. Pharmacol. Ther. 2000 14 : 1249 58.
-
(2000)
Aliment. Pharmacol. Ther.
, vol.14
, pp. 1249-1258
-
-
Kahrilas, P.J.1
Falk, G.W.2
Johnson, D.A.3
-
17
-
-
0034783326
-
Systematic review of proton pump inhibitors for the acute treatment of reflux esophagitis
-
Edwards SJ, Lind T, Lundell L. Systematic review of proton pump inhibitors for the acute treatment of reflux esophagitis. Aliment. Pharmacol. Ther. 2001 15 : 1729 36.
-
(2001)
Aliment. Pharmacol. Ther.
, vol.15
, pp. 1729-1736
-
-
Edwards, S.J.1
Lind, T.2
Lundell, L.3
-
18
-
-
0035114856
-
Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-esophageal reflux disease: A controlled trial of 'on-demand' therapy for 6 months
-
Talley NJ, Lauritsen K, Tunturi-Hihnala H et al. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-esophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment. Pharmacol. Ther. 2001 15 : 347 54.
-
(2001)
Aliment. Pharmacol. Ther.
, vol.15
, pp. 347-354
-
-
Talley, N.J.1
Lauritsen, K.2
Tunturi-Hihnala, H.3
-
19
-
-
0034046560
-
A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects
-
Williams MP, Blanshard C, Millson C et al. A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects. Aliment. Pharmacol. Ther. 2000 14 : 691 9.
-
(2000)
Aliment. Pharmacol. Ther.
, vol.14
, pp. 691-699
-
-
Williams, M.P.1
Blanshard, C.2
Millson, C.3
-
20
-
-
0008422869
-
Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: A double-bind, multicenter, European trial
-
Thjodleifsson B, Becker JA, Dekkers C et al. Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-bind, multicenter, European trial. Dig. Dis. Sci. 2000 45 : 845 53.
-
(2000)
Dig. Dis. Sci.
, vol.45
, pp. 845-853
-
-
Thjodleifsson, B.1
Becker, J.A.2
Dekkers, C.3
-
21
-
-
0021684926
-
Mephenytoin hydroxylation deficiency in Caucasian. Frequency of a new oxidative drug metabolism polymorphism
-
Wedlund PJ, Aslanian WS, McAllister CB, Wilkinson GR, Branch RA. Mephenytoin hydroxylation deficiency in Caucasian. Frequency of a new oxidative drug metabolism polymorphism. Clin. Pharmacol. Ther. 1984 36 : 773 80.
-
(1984)
Clin. Pharmacol. Ther.
, vol.36
, pp. 773-780
-
-
Wedlund, P.J.1
Aslanian, W.S.2
McAllister, C.B.3
Wilkinson, G.R.4
Branch, R.A.5
-
22
-
-
0030444707
-
Genotyping of S-mephenytoin 4′-hydroxylation in an extended Japanese population
-
Kubota T, Chiba K, Ishizaki T. Genotyping of S-mephenytoin 4′-hydroxylation in an extended Japanese population. Clin. Pharmacol. Ther. 1996 60 : 661 6.
-
(1996)
Clin. Pharmacol. Ther.
, vol.60
, pp. 661-666
-
-
Kubota, T.1
Chiba, K.2
Ishizaki, T.3
-
23
-
-
0026705708
-
Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics
-
Sohn DR, Kusaka M, Ishizaki T et al. Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics. Clin. Pharmacol. Ther. 1992 52 : 160 9.
-
(1992)
Clin. Pharmacol. Ther.
, vol.52
, pp. 160-169
-
-
Sohn, D.R.1
Kusaka, M.2
Ishizaki, T.3
-
24
-
-
0024442372
-
Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese
-
Horai Y, Nakano M, Ishizaka T et al. Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland Chinese. Clin. Pharmacol. Ther. 1989 46 : 198 207.
-
(1989)
Clin. Pharmacol. Ther.
, vol.46
, pp. 198-207
-
-
Horai, Y.1
Nakano, M.2
Ishizaka, T.3
-
25
-
-
0026393989
-
The prevalence of Helicobacter pylori infection in the People's Republic of China
-
Li YY, Du Hu PJ, GG et al. The prevalence of Helicobacter pylori infection in the People's Republic of China. Am. J. Gastroenterol. 1991 86 : 446 9.
-
(1991)
Am. J. Gastroenterol.
, vol.86
, pp. 446-449
-
-
Li, Y.Y.1
Du Hu, P.J.G.G.2
-
26
-
-
0036306162
-
Comparison of seroepidemiology of Helicobacter Pylori in Shanghai urban area during 1990 and 2001
-
Chen S, Xiao S, Liu W, Xu W et al. Comparison of seroepidemiology of Helicobacter Pylori in Shanghai urban area during 1990 and 2001. Chin J. Gastroenterol. 2002 7 : 146 8.
-
(2002)
Chin J. Gastroenterol.
, vol.7
, pp. 146-148
-
-
Chen, S.1
Xiao, S.2
Liu, W.3
Xu, W.4
-
27
-
-
0032586730
-
CYP 2C19 genotype status and effect of omeprazole on intragastric pH in humans
-
Furuta T, Ohashi K, Kosuge K et al. CYP 2C19 genotype status and effect of omeprazole on intragastric pH in humans. Clin. Pharmacol. Ther. 1999 65 : 552 61.
-
(1999)
Clin. Pharmacol. Ther.
, vol.65
, pp. 552-561
-
-
Furuta, T.1
Ohashi, K.2
Kosuge, K.3
|